EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Margin Status and Local Recurrence in Early‐Stage Oral‐Cavity Squamous Cell Carcinoma: Analysis of Reresection Outcomes

Hannah J Brown iD, Naomi C Wang, Rahul Alapati, Uma Ramesh, Ameen M Amanian, Andrés M Bur iD

Otolaryngology–Head and Neck Surgery · 2026

DOI: 10.1002/ohn.70343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2026. Verfasst von Hannah J Brown und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, The University of Kansas Medical Center, Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Margins of Excision, Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the impact of surgical margin status and re‐resection on local recurrence (LR) in early‐stage oral cavity squamous cell carcinoma (OCSCC). Study Design Retrospective analysis of 352 patients with cT1‐2N0 OCSCC.

Setting

Tertiary care center from 2005 to 2024.

Methods

Patients were stratified by margin status: initial negative (n = 325), re‐resected to negative (RRN) (n = 20), and positive (n = 7). Initial margin status was determined intraoperatively with frozen sections using specimen‐based or tumor bed–based sampling. Primary outcome was 3‐year LR. Chi‐square tests and Cox proportional hazards models evaluated differences across groups, accounting for potential confounders, for example, adjuvant treatment.

Results

The most common subsite was the tongue (60.2%). 75.9% underwent elective neck dissection. 5.7% had an initial positive margin RRN. 4.8% and 22.7% received adjuvant chemoradiotherapy and radiotherapy, respectively. LR rates were 10.5% for initial negative, 35.0% for RRN, and 42.9% for positive margins despite re‐resection. Compared to patients with initial negative, those with positive (hazard ratio [HR] 5.67, 95% CI 1.74‐18.61) and RRN (HR 3.32, 95% CI 1.47‐7.49) margins showed higher rates of LR. There was no significant difference in LR rates between positive versus RRN margins ( P = .374). After controlling for adjuvant therapy and margin assessment method, positive (aHR 8.32, 95% CI 2.31‐29.9) and RRN (aHR 3.82, 95% CI 1.68‐8.68) margins remained associated with higher LR. Adjuvant therapy trended toward a protective effect (aHR 0.53, 95% CI 0.24‐1.17, P = .117).

Conclusion

RRN margins should not be considered oncologically equivalent to initial negative margins, as demonstrated by higher 3‐year LR rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalMargins of ExcisionMouth NeoplasmsCarcinoma, Squamous CellHumansRetrospective StudiesNeoplasm StagingFemaleMaleMiddle AgedAgedReoperationTreatment OutcomeNeck Dissection

Stichwörter der Autor:innen

Early‐stageadjuvant therapyoral cavitysquamous cell carcinomasurgical margins

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, The University of Kansas Medical Center, Kansas City, Kansas, USA.

ORCID-Profile: Hannah J Brown, Andrés M Bur

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Brown, H. J., Wang, N. C., Alapati, R., Ramesh, U., Amanian, A. M., & Bur, A. M. (2026). Margin Status and Local Recurrence in Early‐Stage Oral‐Cavity Squamous Cell Carcinoma: Analysis of Reresection Outcomes. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70343

Vancouver

Brown HJ, Wang NC, Alapati R, Ramesh U, Amanian AM, Bur AM. Margin Status and Local Recurrence in Early‐Stage Oral‐Cavity Squamous Cell Carcinoma: Analysis of Reresection Outcomes. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70343

BibTeX
@article{Brown2026,
  author = {Brown, Hannah J and Wang, Naomi C and Alapati, Rahul and Ramesh, Uma and Amanian, Ameen M and Bur, Andrés M},
  title = {Margin Status and Local Recurrence in Early‐Stage Oral‐Cavity Squamous Cell Carcinoma: Analysis of Reresection Outcomes},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2026},
  doi = {10.1002/ohn.70343}
}
Kostenlos starten →